Utah researchers are testing whether they can safely inject adult stem cells into patients to prevent and treat acute kidney failure.
Intermountain Medical Center and AlloCure, a Utah-based biotech company, have teamed up to test AlloCure's patented cells in patients who have had open-heart surgery. That kind of major operation can lead to acute kidney injury, which can be deadly. "These cells enable an organ to defend itself against injury," said Christof Westenfelder, AlloCure's chief medical officer.
The researchers are recruiting 15 patients in what they say is the first use of adult stem cells for such kidney problems. The cells are obtained from healthy adult donors' bone marrow. AlloCure grows and processes them in a lab, making them essentially invisible to the patient's immune system so that the patient and donor don't have to match blood or tissue types.
Discuss this item on the forums. (0 posts)
Scientists in Japan have designed artificial molecules which, when used in rats, successfully reversed liver cirrhosis.
